The mechanisms underlying the acquisition of AFP production in neuroendocrine neoplasms remain unclear; however, the identification of genetic abnormalities commonly associated with intrahepatic cholangiocarcinoma suggests a potential derivation from AFP-producing intrahepatic cholangiocarcinoma [2]. This evidence concerns the gene AFP and intrahepatic cholangiocarcinoma.